Literature DB >> 33446893

Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion.

Mingyu Qian1,2, Zihang Chen1,2, Xiaofan Guo1,2, Shaobo Wang1,2, Zongpu Zhang1,2, Wei Qiu1,2, Yanhua Qi1,2, Shouji Zhang1,2, Jianye Xu1,2, Rongrong Zhao1,2, Hao Xue3,4, Gang Li5,6.   

Abstract

Hypoxia is an important feature of the tumor microenvironment and is associated with glioma progression and patient outcome. Exosomes have been implicated in the intercellular communication in the tumor microenvironment. However, the effects of hypoxic glioma exosomes on glioma migration and invasion and the underlying mechanisms remain poorly understood. In this study, we found that exosomes derived from hypoxic glioma cells (H-GDEs) promoted normoxic glioma migration and invasion in vitro and in vivo. Given that exosomes can regulate recipient cell functions by delivering microRNAs, we further revealed miR-1246 and miR-10b-5p were upregulated significantly in H-GDEs and delivered to normoxic glioma cells by H-GDEs. Moreover, we determined the clinical relevance of miR-1246 and miR-10b-5p in glioma patients. Subsequent investigations indicated that miR-1246 and miR-10b-5p markedly induced glioma migration and invasion in vitro and in vivo. Finally, we demonstrated that miR-1246 and miR-10b-5p induced glioma migration and invasion by directly targeting FRK and TFAP2A respectively. In conclusion, our findings suggest that the hypoxic microenvironment stimulates glioma to generate miR-1246- and miR-10b-5p-rich exosomes that are delivered to normoxic glioma cells to promote their migration and invasion; treatment targeting miR-1246 and miR-10b-5p may impair the motility of gliomas, providing a novel direction for the development of antitumor therapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33446893     DOI: 10.1038/s41374-020-00522-0

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.

Authors:  Maya Malaab; Ludivine Renaud; Naoko Takamura; Kip D Zimmerman; Willian A da Silveira; Paula S Ramos; Sandra Haddad; Marc Peters-Golden; Loka R Penke; Bethany Wolf; Gary Hardiman; Carl D Langefeld; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Ann Rheum Dis       Date:  2021-11-08       Impact factor: 19.103

Review 2.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

3.  Integrative analysis of expression profile indicates the ECM receptor and LTP dysfunction in the glioma-related epilepsy.

Authors:  Zhi-Bin Wang; Jian Qu; Pan Xie; Zhi-Quan Yang; Chen-Xue Mao; Ying Zhang; Zheng-Wen He; Zhuan-Yi Yang; Xiao-Yuan Mao; Zhao-Qian Liu
Journal:  BMC Genomics       Date:  2022-06-08       Impact factor: 4.547

Review 4.  Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses.

Authors:  Jinwu Peng; Qiuju Liang; Zhijie Xu; Yuan Cai; Bi Peng; Jianbo Li; Wenqin Zhang; Fanhua Kang; Qianhui Hong; Yuanliang Yan; Mingyu Zhang
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

5.  Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies.

Authors:  Yixin Shi; Bingrun Qiu; Linyang Huang; Jie Lin; Yiling Li; Yiting Ze; Chenglong Huang; Yang Yao
Journal:  PeerJ       Date:  2022-04-26       Impact factor: 3.061

Review 6.  Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects.

Authors:  Hongxia Jiang; Hanqiu Zhao; Mengzhe Zhang; Yuanzhou He; Xiaochen Li; Yongjian Xu; Xiansheng Liu
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

Review 7.  Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment-An Update.

Authors:  Agata M Gawel; Ravi Singh; Waldemar Debinski
Journal:  Biomedicines       Date:  2022-07-05

8.  Cyclooxygenase-2 Upregulated by Temozolomide in Glioblastoma Cells Is Shuttled In Extracellular Vesicles Modifying Recipient Cell Phenotype.

Authors:  Francesca Lombardi; Francesca Rosaria Augello; Serena Artone; Emira Ayroldi; Ilaria Giusti; Vincenza Dolo; Maria Grazia Cifone; Benedetta Cinque; Paola Palumbo
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

9.  The Oral Tumor Cell Exosome miR-10b Stimulates Cell Invasion and Relocation via AKT Signaling.

Authors:  Xiang Li; Ting Yang; Chuanji Shu
Journal:  Contrast Media Mol Imaging       Date:  2022-08-16       Impact factor: 3.009

Review 10.  A Review on the Role of miR-1246 in the Pathoetiology of Different Cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Mohammad Samadian
Journal:  Front Mol Biosci       Date:  2022-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.